Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Tofacitinib may help regrow hair in alopecia areata patients.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tetracycline can stick to hair follicles and potentially cause hair loss.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Baricitinib can cause excessive hair growth.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

Tofacitinib may effectively treat folliculitis decalvans.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Calotropis gigantea and Tridax procumbens extracts reduce inflammation more effectively than low-dose Ibuprofen.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The drug combination was safe and showed promise in treating advanced tumors.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

The new gel improves treatment of tough skin infections.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

A 6-year-old boy developed excessive hair growth after taking diazoxide for low blood sugar.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.